Projecting future drug expenditures—2009

Hoffman, James M.; Shah, Nilay D.; Vermeulen, Lee C.; Doloresco, Fred; Martin, Patrick K.; Blake, Sharon; Matusiak, Linda M.; Hunkler, Robert J.; Schumock, Glen T.

doi:10.2146/ajhp080636

Cited by 35 publications

(32 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[23][24][25][26] As such, to address the issue of unused medications, it would be prudent to base strategies on good prescribing practices, improving patients' medication taking behavior and adherence, increasing awareness about medication cost, and promoting pharmacist involvement in education on medication disposal.…”

Section: Discussionmentioning

confidence: 99%

“…14-18 Studies conducted outside the US are not generalizable due to the differences in health care systems, payment structures, prescribing behaviors, and pattern of medication usage. [19][20][21][22][23][24] Thus, a knowledge gap exists regarding the extent of and reasons for unused prescription medications among households in the US. Given that medication utilization and expenditures in the US has consistently have increased each year, the impact of unused prescription medications on health expenditure also could be substantial.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Taking stock of medication wastage: Unused medications in US households

Law

Sakharkar

Zargarzadeh

et al. 2015

Research in Social and Administrative Pharmacy

174

126

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Taking stock of medication wastage: Unused medications in US households

Law

Sakharkar

Zargarzadeh

et al. 2015

Research in Social and Administrative Pharmacy

174

126

View full text Add to dashboard Cite

“…1 More than 3.8 billion prescriptions are dispensed in the United States each year, costing over $291 billion. 2,3 These medications sometimes lead to significant unintended consequences, which are termed "adverse drug events" (ADEs). The Institute of Medicine estimates that over 1.5 million preventable ADEs occur in the United States each year.…”

Section: What This Study Addsmentioning

confidence: 99%

Geographic Variation in Drug Safety: Potentially Unsafe Prescribing of Medications and Prescriber Responsiveness to Safety Alerts

Feifer

James²

2010

JMCP

View full text Add to dashboard Cite

BACKGROUND: Drug safety issues represent a major cause of morbidity and mortality. Alerting programs are intended to identify patients at potential risk for adverse drug reactions and may provide relevant information to prescribers to support their decision making about clinically appropriate risk reduction. Geographic differences in the incidence of drug safety issues and the responsiveness of prescribers to alerting systems have not been previously studied.

show abstract

“…Antineoplastics are now one of the leading categories of drugs in hospital drug expenditures. 11 Cancer patients and the care they receive are profoundly affected by the increasing costs in a number of ways. In the United States, access to innovative medications can be challenging due to heterogeneity and design of health insurance coverage, as many commercial or governmental programs offer different coverage plans.…”

mentioning

confidence: 99%

Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients

et al. 2016

View full text Add to dashboard Cite

Background:With the advances in cancer treatments, mortality rates in the United States have been consistently falling but they are accompanied by substantial increases in the cost of cancer care. Patient and prescription assistance programs (PPAPs) are offered by pharmaceutical manufacturers to provide free medications to medically indigent patients. To assist the Cancer Care Center (CCC) at Nassau University Medical Center (NUMC) with drug costs for chemotherapies, the pharmacy department uses a patient assistance program (PAP) to obtain medications from the drug companies at no cost. Purpose: This study evaluates the impact of the PAP at a public hospital from which indigent cancer patients obtain assistance for chemotherapy. Methods: We followed all patients requiring assistance with chemotherapy who enrolled in the PAP from January 1, 2011 through December 31, 2012. Medications included both oral and parenteral chemotherapy drugs and antiemetics used in the outpatient clinic setting. Results: The program served 347 patients in 2011 and 579 patients in 2012. The total number of visits in the clinic over 24 months was 9,405. The total cost savings of the medications was $1,066,000 in 2011 and $1,715,538 in 2012. Conclusions: A pharmacy-based PAP to procure free medications from PPAPs for cancer patients has helped to defray the expense of providing care at NUMC, increased patients' compliance with chemo protocols, and allowed many patients to receive the treatment they otherwise would not be able to afford. The combination of PPAPs and PAP provides a safety net to ensure that indigent cancer patients receive needed prescription medications in the outpatient clinic setting.

show abstract

Projecting future drug expenditures—2009

Abstract: In 2009, we project a 0-2% increase in drug expenditures in outpatient settings, a 1-3% increase in expenditures for clinic-administered drugs, and a 1-3% increase in hospital drug expenditures.

Cited by 35 publications

References 45 publications

Taking stock of medication wastage: Unused medications in US households

Taking stock of medication wastage: Unused medications in US households

Geographic Variation in Drug Safety: Potentially Unsafe Prescribing of Medications and Prescriber Responsiveness to Safety Alerts

Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients

Contact Info

Product

Resources

About